Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Next PCSK-9 Pricing Debate: PBM Says Outcomes Data Should Mean Deeper Discount

Dec 09 2016

• By Cole Werble

Related Content

Trump’s Drug Pricing Remarks: A Gambit For Industry Self-Restraint?

Dec 08 2016

The Future Of Specialty Drug Pricing

Nov 14 2016

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Express Scripts Holding Company

Gilead Sciences, Inc.

AbbVie Inc.

GSK plc

Novartis AG

Additional Topics

United States Reimbursement Policy Pricing Debate Cardiovascular BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window